Filing Overview
This Form 8-K was filed by Pono Capital Two, Inc., not SBC Medical Group Holdings Inc. The report concerns events occurring on August 9, 2022, with the filing signed August 17, 2022. Pono Capital Two is a Delaware special purpose acquisition company (SPAC) and an emerging growth company.
Business Context and Transaction
On August 9, 2022, the company completed its initial public offering (IPO) of 11,500,000 units, including 1,500,000 units issued following the underwriters’ full exercise of their over-allotment option.
Each public unit consisted of one Class A common share and one redeemable warrant. Each warrant entitles the holder to purchase one Class A common share at an exercise price of $11.50 per share, subject to adjustment. The units were sold at $10.00 per unit and trade under the symbol PTWOU.
Financial Metrics and Liquidity
| Metric | Amount or Detail |
|---|---|
| Gross IPO proceeds | $115.0 million |
| Private placement proceeds | $6.34375 million |
| Combined gross proceeds | $121.34375 million |
| Funds deposited in trust | $121.34375 million, net of underwriting commissions, discounts, and offering expenses |
| Private placement units | 634,375 units at $10.00 per unit |
The filing does not provide operating revenue, profit, cash flow, margins, debt balances, or other ongoing business performance metrics. An audited balance sheet as of August 9, 2022 was filed as Exhibit 99.1.
Material Changes Versus Prior Period
The material event reported is the completion of the IPO and concurrent private placement. The filing does not present comparative-period financial statements or quantify changes versus a prior comparable period.
Outlook, Risks, and Unusual Items
- Proceeds were placed in a trust account for the benefit of the company’s public stockholders, consistent with the structure of a SPAC.
- The filing does not identify a business combination, acquisition target, revenue guidance, earnings guidance, or operating outlook.
- The principal unusual items are the IPO, the underwriters’ full exercise of the over-allotment option, and the concurrent private placement.
- The filing does not provide specific contingencies or risk updates beyond the transaction disclosures.
Key Facts to Verify
- Verify that this filing belongs to Pono Capital Two, Inc. rather than SBC Medical Group Holdings Inc.
- Review Exhibit 99.1 for the audited post-IPO balance sheet and detailed cash, liabilities, and equity balances.
- Confirm the trust-account balance after all underwriting commissions, discounts, and offering expenses.
- Review the warrant terms, including the $11.50 exercise price and adjustment provisions.
- Monitor subsequent filings for the company’s eventual business combination, redemption terms, and use of trust-account funds.